Which has grown faster, NUTX or OCUL?

Over the past five years, NUTX grew revenue faster — NUTX at a 37.66% CAGR versus OCUL at 10.03%.

Is NUTX or OCUL more profitable?

NUTX runs the higher net margin — NUTX at 21.25% versus OCUL at -579.10%.

How have NUTX and OCUL total returns compared?

Over the past 10 years, NUTX delivered -27.99% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.

Nutex Health, Inc. (NUTX) vs Ocular Therapeutix, Inc. (OCUL)

A side-by-side comparison of Nutex Health, Inc. and Ocular Therapeutix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NUTX

Nutex Health, Inc.

$1.52B

$221.14HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

OCUL

Ocular Therapeutix, Inc.

$1.63B

$7.43HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — NUTX vs OCUL

growth of $100 · dividends reinvested · last 10y

NUTX -96.6% (-28.6%/yr)OCUL +12.9% (+1.2%/yr)OCUL compounded faster over this window

Log scale — wide-divergence pair

NUTX OCUL

NUTX vs OCUL: by the numbers

•OCUL is the larger company ($1.63B vs $1.52B market cap).
•NUTX is profitable (21.25% net margin) while OCUL runs a net loss (-579.10%).
•NUTX grew revenue faster over the past five years (37.66% vs 10.03% CAGR).

Metrics side by side

Valuation

Metric	NUTX	OCUL
P/E ratio	8.75	N/A
Forward P/E	7.96	N/A
P/S ratio	1.80	31.24
P/B ratio	3.86	3.13
EV / EBITDA	4.32	N/A
FCF yield	18.02%	N/A

Profitability

Metric	NUTX	OCUL
Gross margin	51.26%	87.11%
Operating margin	31.49%	-521.04%
Net margin	21.25%	-579.10%
ROE	45.63%	-57.97%
ROIC	33.76%	-50.20%

Growth (annualized)

Metric	NUTX	OCUL
Revenue CAGR (5Y)	37.66%	10.03%
EPS CAGR (5Y)	-14.73%	N/A
Total return CAGR (5Y)	-18.99%	-5.73%

Frequently asked

Which has grown faster, NUTX or OCUL?: Over the past five years, NUTX grew revenue faster — NUTX at a 37.66% CAGR versus OCUL at 10.03%.
Is NUTX or OCUL more profitable?: NUTX runs the higher net margin — NUTX at 21.25% versus OCUL at -579.10%.
How have NUTX and OCUL total returns compared?: Over the past 10 years, NUTX delivered -27.99% and OCUL delivered 0.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NUTX analysis Full OCUL analysis Interactive comparison tool

Dig into the metrics

Nutex Health P/E ratio Nutex Health ROE Ocular Therapeutix ROE Nutex Health operating margin Ocular Therapeutix operating margin Nutex Health revenue growth Ocular Therapeutix revenue growth Nutex Health free cash flow Ocular Therapeutix free cash flow

Nutex Health & Ocular Therapeutix appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.